Literature DB >> 35836072

BRET Sensors for Imaging Membrane Integrity of Microfluidically Generated Extracellular Vesicles.

Ramasamy Paulmurugan1,2, Yi Liu3,4, Uday Kumar Sukumar3,4, Masamitsu Kanada3,4, Tarik F Massoud3,4.   

Abstract

Extracellular vesicles (EVs) derived from various cell lines have been extensively used as natural nanodelivery vehicles for drug, protein, and nucleic acid deliveries in therapeutic applications for cancer. Recently, we developed a microfluidic-based reconstruction strategy as a novel method to generate microRNA-loaded membrane vesicles for cancer therapy in vivo. We used EVs and cell membranes isolated from different source of cells for this reconstruction process. The microfluidic system produced reconstructed vesicles of uniform sizes with high microRNA loading efficiency independent of input membrane sources (EVs or cell membranes). To address the functional integrity of the membrane structure and of proteins in the reconstructed EVs, we introduce a membrane-insertable bioluminescence resonance energy transfer (BRET) sensor system. This sensor, with its membrane-insertable palmitoylation signal peptide sequence derived from a growth-associated protein 43 (GAP43), helps in trafficking the fusion protein to the cell membrane upon its expression in cells and allows for imaging reconstructed membrane vesicles using optical imaging. In this chapter, we detail the stepwise methods used for the engineering of cells using this sensor, isolation of EVs from the engineered cells, preparation of reconstructed EVs by microfluidic processing, and BRET imaging of reconstructed EVs for membrane integrity evaluation.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  BRET; Bioluminescence; Cancer cell membrane; Extracellular vesicles; Fluorescence; Imaging; Microfluidics

Mesh:

Substances:

Year:  2022        PMID: 35836072     DOI: 10.1007/978-1-0716-2473-9_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

Review 1.  Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.

Authors:  Rammohan Devulapally; Ramasamy Paulmurugan
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-08-31

2.  Microvesicle-Mediated Delivery of Minicircle DNA Results in Effective Gene-Directed Enzyme Prodrug Cancer Therapy.

Authors:  Masamitsu Kanada; Bryan D Kim; Jonathan W Hardy; John A Ronald; Michael H Bachmann; Matthew P Bernard; Gloria I Perez; Ahmed A Zarea; T Jessie Ge; Alicia Withrow; Sherif A Ibrahim; Victoria Toomajian; Sanjiv S Gambhir; Ramasamy Paulmurugan; Christopher H Contag
Journal:  Mol Cancer Ther       Date:  2019-08-26       Impact factor: 6.261

3.  The fate and toxicity of Raman-active silica-gold nanoparticles in mice.

Authors:  Avnesh S Thakor; Richard Luong; Ramasamy Paulmurugan; Frank I Lin; Paul Kempen; Cristina Zavaleta; Pauline Chu; Tarik F Massoud; Robert Sinclair; Sanjiv S Gambhir
Journal:  Sci Transl Med       Date:  2011-04-20       Impact factor: 17.956

4.  Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.

Authors:  Sayan Mullick Chowdhury; Taehwa Lee; Sunitha V Bachawal; Rammohan Devulapally; Lotfi Abou-Elkacem; Tristan Alan Yeung; Jennifer Wischhusen; Lu Tian; Jeremy Dahl; Ramasamy Paulmurugan; Juergen Karl Willmann
Journal:  J Control Release       Date:  2018-05-24       Impact factor: 9.776

5.  Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents.

Authors:  Rajendran J C Bose; Sukumar Uday Kumar; Yitian Zeng; Rayhaneh Afjei; Elise Robinson; Kenneth Lau; Abel Bermudez; Frezghi Habte; Sharon J Pitteri; Robert Sinclair; Juergen K Willmann; Tarik F Massoud; Sanjiv S Gambhir; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2018-10-22       Impact factor: 15.881

6.  Folate Receptor-Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple-Negative Breast Cancer.

Authors:  Ramasamy Paulmurugan; Rohith Bhethanabotla; Kaushik Mishra; Rammohan Devulapally; Kira Foygel; Thillai V Sekar; Jeyarama S Ananta; Tarik F Massoud; Abraham Joy
Journal:  Mol Cancer Ther       Date:  2015-11-09       Impact factor: 6.261

7.  Minicircles for a two-step blood biomarker and PET imaging early cancer detection strategy.

Authors:  Elise R Robinson; Gayatri Gowrishankar; Aloma L D'Souza; Azadeh Kheirolomoom; Tom Haywood; Sharon S Hori; Hui-Yen Chuang; Yitian Zeng; Spencer K Tumbale; Amin Aalipour; Corinne Beinat; Israt S Alam; Ataya Sathirachinda; Masamitsu Kanada; Ramasamy Paulmurugan; Katherine W Ferrara; Sanjiv S Gambhir
Journal:  J Control Release       Date:  2021-05-21       Impact factor: 11.467

8.  Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.

Authors:  Rajendran J C Bose; Nagendran Tharmalingam; Fernando J Garcia Marques; Uday Kumar Sukumar; Arutselvan Natarajan; Yitian Zeng; Elise Robinson; Abel Bermudez; Edwin Chang; Frezghi Habte; Sharon J Pitteri; Jason R McCarthy; Sanjiv S Gambhir; Tarik F Massoud; Eleftherios Mylonakis; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2020-05-04       Impact factor: 18.027

9.  Polymer nanoparticles mediated codelivery of antimiR-10b and antimiR-21 for achieving triple negative breast cancer therapy.

Authors:  Rammohan Devulapally; Narayana M Sekar; Thillai V Sekar; Kira Foygel; Tarik F Massoud; Jürgen K Willmann; Ramasamy Paulmurugan
Journal:  ACS Nano       Date:  2015-02-23       Impact factor: 15.881

Review 10.  Extracellular vesicle-based drug delivery systems for cancer treatment.

Authors:  Sierra Walker; Sara Busatto; Anthony Pham; Ming Tian; Annie Suh; Kelsey Carson; Astrid Quintero; Maria Lafrence; Hanna Malik; Moises X Santana; Joy Wolfram
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.